3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
12
Neurofibroma, Plexiform
6
Carcinoma, Non-Small-Cell Lung
4
Neurofibrosarcoma
3
Neoplasms
3
Lung Neoplasms
3
Melanoma
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Muscle Invasive Bladder Cancer
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gallbladder Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Astrocytoma
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma
1
Interventions
Cyclophosphamide
28
Temozolomide
25
Irinotecan
21
dinutuximab
20
Topotecan
15
Magnetic Resonance Spectroscopy
13
Specimen Handling
12
Biopsy
12
naxitamab
11
Granulocyte-Macrophage Colony-Stimulating Factor
11
3-Iodobenzylguanidine
11
Vincristine
10
Etoposide
10
sargramostim
9
Melphalan
9
Isotretinoin
9
fludarabine
8
X-Rays
8
Colony-Stimulating Factors
8
Carboplatin
8
etoposide phosphate
7
Phantoms, Imaging
7
Doxorubicin
7
fludarabine phosphate
6
Stem Cell Transplantation
6
Nuclear Medicine Department, Hospital
6
Eflornithine
6
Thiotepa
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
AZD 6244
×
1 year
×
Clear all
No trials found.